edoc-vmtest

Items where Author is "Lerch, S."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: Article
Number of items: 3.

Article

Rochlitz, C. and Ruhstaller, T. and Lerch, S. and Spirig, C. and Huober, J. and Suter, T. and Buhlmann, M. and Fehr, M. and Schonenberger, A. and von Moos, R. and Winterhalder, R. and Rauch, D. and Muller, A. and Mannhart-Harms, M. and Herrmann, R. and Cliffe, B. and Mayer, M. and Zaman, K.. (2011) Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06). Annals of Oncology, Vol. 22, H. 1. pp. 80-85.

Amrhein, V. and Lerch, S.. (2010) Differential effects of moving versus stationary territorial intruders on territory defence in a songbird. The journal of animal ecology, Vol. 79, H. 1. pp. 82-87.

D'Addario, G. and Rauch, D. and Stupp, R. and Pless, M. and Stahel, R. and Mach, N. and Jost, L. and Widmer, L. and Tapia, C. and Bihl, M. and Mayer, M. and Ribi, K. and Lerch, S. and Bubendorf, L. and Betticher, D. C.. (2008) Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC) : SAKK protocol 19/03. Annals of Oncology, Vol. 19. pp. 739-745.

This list was generated on Mon Dec 23 05:00:46 2024 CET.